Abstract

We have investigated the possibility of a direct regulatory effect of gonadotrophin releasing hormone (GnRH) analogues on prostatic cancer cell growth. Here we report high affinity binding (Kd = 50 nM) of a GnRH analogue resulting in biphasic growth modulation of the human androgen-sensitive prostatic cancer cell line LNCaP. In contrast, the human androgen-insensitive prostatic cancer cell line DU145 showed low-affinity (Kd = 10 microM) binding without any biological response to the GnRH analogue. A GnRH-specific radioimmunoassay demonstrated GnRH-like immunoreactivity in the concentrated culture medium from both cell lines. Seventy-six human benign and malignant tumours were assayed following surgical resection. Nineteen of 22 (86%) malignant tumours and 49 of 54 (91%) benign tumours, exhibited high affinity GnRH-analogue binding. Fourteen of 19 (74%) malignant tumours and 17 of 49 (35%) benign tumours exhibiting high affinity binding contained GnRH-like immunoreactivity, suggesting that this system may be involved in prostatic epithelial cell growth in vivo.

Highlights

  • This present study explored the direct effects of gonadotrophin releasing hormone (GnRH) analogues on prostatic cancer cells in culture and in vivo

  • The LNCaP cells showed high affinity binding of buserelin with 50% inhibition obtained at 50 nM concentration of unlabelled peptide

  • A Scatchard plot of the same data indicated a single class of binding sites with Kd = 40 nM (Figure 3)

Read more

Summary

Methods

The human androgen-sensitive prostatic cancer cell line LNCaP (isolated from lymph node metastasis; Horoszewicz et al, 1983) and the human androgen-insensitive prostatic cell line DU145 (isolated from brain metastasis) were obtained from the American Type Culture Collection. Cultures were maintained in exponential growth in RPMI 1640 medium containing 10% charcoal stripped fetal calf serum and 5 fig ml-I insulin. The fetal calf serum used in cell culture medium was treated with dextran and charcoal to remove steroids. Charcoal 0.25% and dextran-T70 0.025% were added to the serum, which was heated at 56'C for 2 h and centrifuged at 4,000 r.p.m. for O min. The pellet was discarded, serum was filtered through 0.4 ltm filters and Correspondence: J.

Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.